Altium Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-400,000
| Closed | -$4.01M | – | 140 |
|
|
2022
Q3 | $4.01M | Hold |
400,000
| – | – | 1.47% | 21 |
|
|
2022
Q2 | $3.96M | Hold |
400,000
| – | – | 1.58% | 18 |
|
|
2022
Q1 | $3.94M | Hold |
400,000
| – | – | 1.32% | 31 |
|
|
2021
Q4 | $3.9M | Hold |
400,000
| – | – | 1.08% | 35 |
|
|
2021
Q3 | $3.91M | Hold |
400,000
| – | – | 1.03% | 39 |
|
|
2021
Q2 | $3.94M | Buy |
+400,000
| New | +$3.94M | 0.91% | 40 |
|